Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dahl

Showing results (151-160 of 521) with videos related to

Pageof 53
Sort By:
Journal of the Neurological Sciences|August 7, 2002
Clinical and molecular features of adPEO due to mutations in the Twinkle geneSharon Lewis, Wendy Hutchison, Dominic Thyagarajan, et al.
The Journal of Organic Chemistry|October 24, 2001
Highly Stereoselective Kinetic Enolate Formation: Steric vs Electronic EffectsLinfeng Xie, Kurt M. Isenberger, Gary Held, et al.
Trends in Cardiovascular Medicine|May 26, 2012
Bioengineered vascular grafts: can we make them off-the-shelf?Shannon L M Dahl, Juliana L Blum, Laura E Niklason
AJR. American Journal of Roentgenology|May 25, 2011
Prostate cancer imaging: what surgeons, radiation oncologists, and medical oncologists want to knowShahin Tabatabaei, Philip J Saylor, John Coen, et al.
Acta Anaesthesiologica Scandinavica|November 23, 2011
Tissue gas tensions and tissue metabolites for detection of organ hypoperfusion and ischemiaL Waelgaard, B M Dahl, G Kvarstein, et al.
Journal of Medicinal Chemistry|February 15, 2001
Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5S Zoffmann, G Turcatti, J Galzi, et al.
The Journal of Allergy and Clinical Immunology|May 10, 2001
Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletionM Dahl, B G Nordestgaard, P Lange, et al.
Cancer|July 1, 1989
A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive diseaseI M Dahl, O P Solheim, B Erikstein, et al.
Cancer|November 15, 1987
Progressive loss of vision in patients with high-grade non-Hodgkin's lymphomaH Holte, G Saeter, I M Dahl, et al.
American Journal of Obstetrics & Gynecology MFM|April 13, 2024
Pregnancy planning, prevention, and risk evaluation clinics: rethinking the traditional preconception consultCarly M Dahl, Kathryn E Fay, Steffanie Wright, et al.
Pageof 53

Showing results (151-160 of 521) with videos related to

Sort By:
Pageof 53
Journal of the Neurological Sciences|August 7, 2002
Clinical and molecular features of adPEO due to mutations in the Twinkle geneSharon Lewis, Wendy Hutchison, Dominic Thyagarajan, et al.
The Journal of Organic Chemistry|October 24, 2001
Highly Stereoselective Kinetic Enolate Formation: Steric vs Electronic EffectsLinfeng Xie, Kurt M. Isenberger, Gary Held, et al.
Trends in Cardiovascular Medicine|May 26, 2012
Bioengineered vascular grafts: can we make them off-the-shelf?Shannon L M Dahl, Juliana L Blum, Laura E Niklason
AJR. American Journal of Roentgenology|May 25, 2011
Prostate cancer imaging: what surgeons, radiation oncologists, and medical oncologists want to knowShahin Tabatabaei, Philip J Saylor, John Coen, et al.
Acta Anaesthesiologica Scandinavica|November 23, 2011
Tissue gas tensions and tissue metabolites for detection of organ hypoperfusion and ischemiaL Waelgaard, B M Dahl, G Kvarstein, et al.
Journal of Medicinal Chemistry|February 15, 2001
Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5S Zoffmann, G Turcatti, J Galzi, et al.
The Journal of Allergy and Clinical Immunology|May 10, 2001
Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletionM Dahl, B G Nordestgaard, P Lange, et al.
Cancer|July 1, 1989
A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive diseaseI M Dahl, O P Solheim, B Erikstein, et al.
Cancer|November 15, 1987
Progressive loss of vision in patients with high-grade non-Hodgkin's lymphomaH Holte, G Saeter, I M Dahl, et al.
American Journal of Obstetrics & Gynecology MFM|April 13, 2024
Pregnancy planning, prevention, and risk evaluation clinics: rethinking the traditional preconception consultCarly M Dahl, Kathryn E Fay, Steffanie Wright, et al.
Pageof 53